AMERICAN TIMEZONE  2 am EDT

Are you curious about potential applications of genomics or machine learning?  Have you ever wondered how the GARD test platform works?  This presentation will provide a comprehensive explanation on how genomics and machine learning have been combined to create the GARD test platform for in vitro testing of respiratory and skin sensitizers.  This will include an in-depth explanation of this unique technology, how it works, and why it is highly accurate and has such robust prediction. 

This presentation will include discussions on:

• The background of the genomic-based GARD™ test with an accuracy over 90% and how it compares and combines with other in vivo and in vitro sensitization assays
• Comprehensive description of the GARD algorithm and how the technology actually works
  • Genomics as a tool for analysis of immunotoxicological responses
  • Method development steps beginning with screening the entire human genome on array platforms for relevant biomarkers to a streamlining the analytical model. This will include the benefits of a data driven approach in test development providing a holistic view of the immunological response.
  • A short introduction and explanation of the prediction model and how machine learning algorithms are applied for classifying results. What does the model do? Does it change? How can pattern recognition models be applied to biological gene expression data?
• One platform enabling several tests – How is this possible?
• Simple to use, easy and transparent classifications, no expert judgements required
• Applicability of the GARD™platform – What chemicals can I test in GARD? How can this in vitro test analyse “difficult to test substances”, mixtures, pre-pro haptens, UVCBs, etc? Including GARD test cases and what types of chemicals have been tested already.
• Where can I get my testing done?

What should I know before the webinar?
No previous knowledge about GARD is required. No technical background on genomics, machine learning algorithms, or programming required. No bioinformatics or immunological expertise required.

Who should attend? 

• Anyone interested in the GARD technology.
• Regulators, policymakers, or CROs who want to understand more about the technology.
• Safety Assessors, Responsible Persons, Product Development managers and testers, Product Safety managers and assistants, Lab personnel, and anyone concerned with assessing product safety or toxicology.
• Anyone interested in learning about genomics and next generation animal-free test development for hazard assessments

For registration KLICK HERE